Highly Sensitive Viral Detection with the SARS-CoV-2 NGS Assay

Kristin Butcher and Mara Cuoto-Rodriguez discuss the development of a nucleic acid hybridization capture-based assay to detect and identify novel SARS-CoV-2 variants.

Event Details:Highly Sensitive Viral Detection with the SARS-CoV-2 NGS AssayDate(s):

FREE Webinar

Thursday, May 20, 2021
12:00 - 1:30 PM Eastern Time

The COVID-19 pandemic highlights a need for the rapid development of detection strategies and assays for novel pathogens. The SARS-CoV-2 NGS Assay is a highly sensitive nucleic acid hybridization capture-based assay that detects the SARS-CoV-2 viral genome. This FDA-authorized-under-emergency-use assay combines virus-specific panels and comprehensive data analysis software and reporting capabilities to provide researchers with information on genetic variants, clade-associated variants, and phylogenetics. In this webinar brought to you by Twist Bioscience, Kristin Butcher and Mara Cuoto-Rodriguez will demonstrate the SARS-CoV-2 NGS assay technology and describe how researchers use it to detect and identify novel variants of the SARS-CoV-2 virus.

Topics to be covered

Register Now

Meet the Speakers:

Kristin Butcher
Senior Scientist
Twist Bioscience

Mara Couto-Rodriguez
Director of Research and Development
Biotia

Sponsored by

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!

Join for free today

Already a member? Login Here